Detalhe da pesquisa
1.
EptA of Riemerella anatipestifer mediates phenotypes involved in colistin resistance and virulence.
FASEB J
; 37(5): e22928, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071453
2.
FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinoma.
Cell Immunol
; 379: 104577, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35870429
3.
Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial.
BMC Cancer
; 21(1): 1033, 2021 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34530760
4.
PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas.
Exp Cell Res
; 395(2): 112187, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721391
5.
Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
Int J Med Sci
; 18(6): 1510-1518, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33628109
6.
Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.
Exp Cell Res
; 379(2): 203-213, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30978341
7.
Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.
Oncologist
; 24(Suppl 1): S21-S30, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819828
8.
Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinoma.
Anticancer Drugs
; 30(8): 873-878, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31283542
9.
Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies.
Lung
; 193(5): 805-14, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119960
10.
Everolimus and zoledronic acid--a potential synergistic treatment for lung adenocarcinoma bone metastasis.
Acta Biochim Biophys Sin (Shanghai)
; 46(9): 792-801, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25098623
11.
Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis.
Int J Biol Sci
; 20(2): 537-553, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38169676
12.
EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment.
Lung Cancer
; 192: 107815, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754276
13.
Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC.
Ther Adv Med Oncol
; 15: 17588359231156387, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895853
14.
Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure.
Front Oncol
; 13: 1265236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37869096
15.
Comprehensive molecular characterizations of stage I-III lung adenocarcinoma with tumor spread through air spaces.
Front Genet
; 14: 1101443, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816028
16.
Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib.
Ther Adv Med Oncol
; 15: 17588359231216089, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145112
17.
Functional Characterization of a Novel SMR-Type Efflux Pump RanQ, Mediating Quaternary Ammonium Compound Resistance in Riemerella anatipestifer.
Microorganisms
; 11(4)2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37110330
18.
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial.
EClinicalMedicine
; 59: 101952, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096188
19.
Comparison of Efficacy and Safety of Brigatinib in First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison.
J Clin Med
; 11(11)2022 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35683354
20.
Treatment preferences for epidermal growth factor receptor mutation-positive non-small cell lung cancer with brain metastasis: a large-scale survey from Chinese oncologists.
Ann Transl Med
; 10(2): 41, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35282104